Kuang Shida, Liu Lumei, Hu Zongren, Luo Min, Fu Xinying, Lin Chengxiong, He Qinghu
College of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China; Andrology Laboratory, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China; Hunan University of Medicine, Huaihua, Hunan 418000, China.
College of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China; Hunan University of Medicine, Huaihua, Hunan 418000, China.
Int J Biol Macromol. 2023 Feb 15;228:582-593. doi: 10.1016/j.ijbiomac.2022.12.153. Epub 2022 Dec 20.
Osteoarthritis (OA) is a chronic joint disease characterized by progressive cartilage degeneration, which imposes a heavy physical and financial burden on the middle-aged and elderly population. As the pathogenesis of OA has not been fully elucidated, it is of great importance to develop targeted therapeutic or preventive medications. Traditional therapeutic drugs, such as non-steroidal anti-inflammatory drugs, steroids and opioids, have significant side effects, making the exploration for safe and effective alternative therapeutic drugs urgent. In recent years, many studies have reported the role of plant-derived polysaccharides in anti-inflammation, anti-oxidation, regulation of chondrocyte metabolism and proliferation, and cartilage protection, and have demonstrated their great potential in the treatment of OA. Therefore, by focusing on studies related to the intervention of plant-derived polysaccharides in OA, including in vivo and in vitro experiments, this review aimed to classify and summarize the existing research findings according to different mechanisms of action. In addition, reports on plant-derived polysaccharides as nanoparticles were also explored. Then, candidate monomers and theoretical bases were provided for the further development and application of novel drugs in the treatment of OA.
骨关节炎(OA)是一种以软骨进行性退变为特征的慢性关节疾病,给中老年人群带来了沉重的身体和经济负担。由于OA的发病机制尚未完全阐明,开发有针对性的治疗或预防药物具有重要意义。传统治疗药物,如非甾体抗炎药、类固醇和阿片类药物,具有显著的副作用,因此迫切需要探索安全有效的替代治疗药物。近年来,许多研究报道了植物源多糖在抗炎、抗氧化、调节软骨细胞代谢和增殖以及保护软骨方面的作用,并证明了它们在OA治疗中的巨大潜力。因此,通过关注与植物源多糖干预OA相关的研究,包括体内和体外实验,本综述旨在根据不同的作用机制对现有研究结果进行分类和总结。此外,还探讨了关于植物源多糖作为纳米颗粒的报道。然后,为新型药物在OA治疗中的进一步开发和应用提供了候选单体和理论依据。